| Ytd | 136.02% | |
| 1y | 154.03% |
| Open | 29.63 | Prev Close | 29.53 | Low | 29.23 | High | 30.96 | Mkt Cap | 2.05B |
| Vol | 518.74K | Avg Vol | 278.59K | EPS | -1.00 | P/E | -29.96 | Forward P/E | -16.34 |
| Beta | 1.29 | Short Ratio | 8.13 | Inst. Own | 69.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 25.79 | 200-d Avg | 18.41 | 1yr Est | 42.89 |
GHRS News
Alignment with FDA on CMC and device plans for Phase 3 Successfully completed GH001-HV-106 and GH001
GH Research PLC (NASDAQ:GHRS) and Definium Therapeutics Inc. (NASDAQ:DFTX) stocks are trading higher
GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session
CleanSpark Inc (NASDAQ:CLSK) shares surged more than 12% after the company announced a 20-year lease
Tower Semiconductor (NASDAQ:TSEM) shares rose 13% on Tuesday after the company announced a strategic
The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the
DUBLIN, June 04, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS) today announced the publica
GH Research is advancing GH001, an inhalable mebufotenin therapy, in treatment-resistant depression.
GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.
Phase 2b results in TRD published in JAMA Psychiatry GH001-HV-106 study enrolment completed; doses s
Health officials explored restricting specific antidepressants among SSRI drugs-sources
DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharm
FTSE 100 down 35 points at 10,574 Markets await confirmation of US-Iran talks UK bond eyes developme
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer
DUBLIN, April 20, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharm
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump
Shares of psychedelics-related stocks climbed in early trade on Monday after US president Donald Tru
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
Prenetics Global (NASDAQ: PRE - Get Free Report) and GH Research (NASDAQ: GHRS - Get Free Report) ar
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t
DUBLIN, March 25, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharm
GH Research PLC remains well-capitalized with $280.7 million in cash, supporting its lead candidate
Completed Phase 2b trial of GH001 in TRD and presented the full dataset at the 2025 ASCP and ECNP co
The U.S. Food and Drug Administration (FDA) on Monday lifted the clinical hold on GH Research Plc's
The FDA lifted its clinical hold on GH Research's GH001 after Phase 2b data showed rapid, durabl
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollment Company to se
On Monday, 198 companies hit new 52-week lows.
Gainers
On Tuesday, 540 companies set new 52-week lows.
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday a